Log in to MyACC
Nonstatin Strategies and Therapies for LDL-C Lowering Pocket Guide
The following resource contains figures from the 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease (ASCVD) Risk to guide clinician decision-making on the optimization of statin therapies in accordance with clinical guidelines and practical guidance on the use of nonstatin therapies.
This resource is only an excerpt from the manuscript published in Journal of the American College of Cardiology (JACC) and the full publication should be reviewed for important context and additional information.
This pocket guide is supported by Esperion.
